Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Literature
1.
Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92:1203–1208PubMedCrossRef
2.
Schalin-Jäntti C, Mornet E, Lamminen A, Välimaki MJ (2010) Parathyroid hormone replacement improves pain and fracture healing in adult hypophophatasia. J Clin Endocrinol Metab 95:5174–5179PubMedCrossRef
3.
Yadav MC, Lemire I, Leonard P, Boileau G, Blond L, Beliveau M, Cory E, Sah RL, Whyte MP, Crine P, Millán JL (2011) Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone 49:250–256PubMedCrossRef
Metadata
Title
Failure of Teriparatide in Treatment of Bone Complications of Adult Hypophosphatasia
Author
Michel Laroche
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 3/2012
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-011-9562-5

Other articles of this Issue 3/2012

Calcified Tissue International 3/2012 Go to the issue

Original Research

Osteocyte Apoptosis and Absence of Bone Remodeling in Human Auditory Ossicles and Scleral Ossicles of Lower Vertebrates: A Mere Coincidence or Linked Processes?

Original Research

Microarray Profiling of Diaphyseal Bone of Rats Suffering from Hypervitaminosis A

Original Research

Soft Tissue Composition and the Risk of Low Bone Mineral Density: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-3), 2009

Original Research

Effect of Dosing Interval Duration of Intermittent Ibandronate Treatment on the Healing Process of Femoral Osteotomy in a Rat Fracture Model

Original Research

Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis

Original Research

Femoral Neck Bone Strength Estimated by Hip Structural Analysis (HSA) in Swedish Caucasians Aged 6–90 Years

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits